Prosonix is an innovative speciality pharmaceutical company developing a portfolio of inhaled respiratory medicines by design
Latest News
Feb 11, 2013
Prosonix Appoints Cécile Miles as Chief Business Officer
Jan 7, 2013
Prosonix Receives £1.3M Grant Award from the Biomedical Catalyst to Accelerate Development of...
Dec 5, 2012
Prosonix Elects Dr Ken Cunningham as Non-executive Chairman
Events
22-23 May 2013
Stockholm, Sweden
21-24 May 2013
Berlin, Germany
Terms & Conditions
© Prosonix Ltd, 2013
The Magdalen Centre   Robert Robinson Avenue   Oxford Science Park   Oxford   OX4 4GA   United Kingdom   |   Tel: +44 (0)1865 784250   |   Email: Here